These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6207157)

  • 21. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
    Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
    Courtenay VD; Mills J; Steel GG
    Br J Cancer; 1982 Sep; 46(3):436-9. PubMed ID: 6215052
    [No Abstract]   [Full Text] [Related]  

  • 24. UICC Study Group on chemosensitivity testing of human tumors. Problems--applications--future prospects.
    Pihl A
    Int J Cancer; 1986 Jan; 37(1):1-5. PubMed ID: 3941017
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bleomycin induced flagellate dermatitis: a new clinical case].
    Narimane S; Errihani H
    Pan Afr Med J; 2016; 25():86. PubMed ID: 28292049
    [No Abstract]   [Full Text] [Related]  

  • 26. A replenishable soft agar colony assay for human tumour sensitivity testing.
    Courtenay VD
    Recent Results Cancer Res; 1984; 94():17-34. PubMed ID: 6494577
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo.
    Caffrey PB; Zhang Y; Frenkel GD
    Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
    Takamizawa H; Sekiya S; Iwasawa H; Ishige H; Tokita H; Tanaka N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2293-7. PubMed ID: 2416274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
    Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.
    Von Hoff DD; Clark GM; Weiss GR; Marshall MH; Buchok JB; Knight WA; LeMaistre CF
    J Clin Oncol; 1986 Dec; 4(12):1827-34. PubMed ID: 2431110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Establishment of a cell line from human ovarian cancer (undifferentiated carcinoma of FIGO classification) and analysis of its cell-biological characteristics and sensitivity to anticancer drugs].
    Yoshiya N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1747-53. PubMed ID: 3782955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term in vitro chemosensitivity testing of tumours of the ovary, cervix and uterus. Measurement of DNA metabolism by 3H thymidine incorporation.
    Khoo SK; Hurst T; Webb MJ; Mackay EV
    Aust N Z J Obstet Gynaecol; 1986 Nov; 26(4):288-94. PubMed ID: 3469997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
    Fuchs J; Wenderoth M; von Schweinitz D; Haindl J; Leuschner I
    Cancer; 1998 Dec; 83(11):2400-7. PubMed ID: 9840541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of human head and neck cancer xenografts with three clinically active drugs: cis-platinum, bleomycin and methotrexate.
    Braakhuis BJ; Schoevers EJ; Heinerman EC; Sneeuwloper G; Snow GB
    Br J Cancer; 1983 Nov; 48(5):711-6. PubMed ID: 6196043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
    Tofilon PJ; Basic I; Milas L
    Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three tumor sensitivity tests evaluated with mouse tumors.
    Lelieveld P; Mulder JH
    Int J Cell Cloning; 1987 Jul; 5(4):335-46. PubMed ID: 3476675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antineoplastic polychemotherapy in thoracic pathology].
    Mannes P; Derriks R; Moens R; Heynen E
    Poumon Coeur; 1968; 24(1):83-91. PubMed ID: 4968018
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemosensitivity test for gynecologic malignancies by in vitro colony assay].
    Kano T; Nishida Y; Sakakibara K; Ohta M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2827-36. PubMed ID: 4086909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.